8-KRegulation FD

HCA Healthcare, Inc. 8-K Report, Regulation FD Disclosure (Jan 10, 2012)

Filed January 10, 2012For Securities:HCA

Summary

HCA Holdings, Inc. (HCA) filed an 8-K on January 10, 2012, to disclose preliminary fourth-quarter results and provide an update ahead of their presentation at the J.P. Morgan Healthcare Conference. The company indicated that it expects to meet or exceed its previously issued guidance for full-year 2011 Adjusted EBITDA growth of 0-2%. This positive outlook is attributed to continued solid volume growth despite pressures from Medicaid reimbursement reductions and lower acuity levels, offset by effective expense management. HCA also noted that the guidance included HITECH revenues and related expenses but excluded any financial impact from the recent acquisition of the HealthOne venture minority interest. Investors should note that these are preliminary results and are subject to finalization. The company explicitly stated that they would not provide further details on the fourth quarter until their official earnings release scheduled for February 2nd and would defer providing 2012 guidance to that same event. The filing also included a comprehensive cautionary statement highlighting numerous risks and uncertainties that could affect future performance, including debt levels, healthcare reform impacts, reimbursement changes, competitive pressures, and operational challenges.

Key Highlights

  • 1HCA expects to achieve full-year 2011 Adjusted EBITDA growth at the upper end or slightly above its previously guided range of 0-2%.
  • 2The positive EBITDA outlook is supported by continued solid volume growth in the fourth quarter.
  • 3Despite volume growth, the company experienced revenue rate pressures primarily due to Medicaid reimbursement reductions and lower patient acuity.
  • 4Effective expense management, a theme from the third quarter, continued to be a key driver in the fourth quarter.
  • 5Preliminary results are subject to finalization of fourth-quarter and year-end financial and accounting procedures.
  • 6HCA did not provide specific fourth-quarter 2011 financial figures in this filing, deferring them to the February 2nd earnings release.
  • 7Guidance for fiscal year 2012 will also be provided on the February 2nd earnings call.

Frequently Asked Questions

The main takeaway is that HCA is projecting to meet or exceed its full-year 2011 Adjusted EBITDA growth guidance of 0-2%, driven by strong volume growth and effective cost controls, despite some revenue rate pressures.

HCA plans to release its full fourth-quarter and full-year 2011 results and provide its 2012 guidance on February 2nd, 2012, during its scheduled earnings release and investor call.

HCA is experiencing revenue rate pressures primarily due to reductions in Medicaid reimbursement and a decrease in the acuity of patients being treated.

No, this filing explicitly states that HCA will not comment on expectations for 2012 results and will provide 2012 guidance in conjunction with its fourth-quarter earnings release on February 2nd.